Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interes...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/230e01384c354a898aa66ccf47cbe072 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:230e01384c354a898aa66ccf47cbe072 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:230e01384c354a898aa66ccf47cbe0722021-11-08T02:35:28ZRecent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods1741-428810.1155/2021/5738900https://doaj.org/article/230e01384c354a898aa66ccf47cbe0722021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5738900https://doaj.org/toc/1741-4288Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interest in discovering new URAT1 inhibitors and developing technology that can evaluate URAT1 inhibition. This review summarizes the methods for assay of URAT1 inhibition and the progress on the discovery of natural and synthetic URAT1 inhibitors in the past five years.Ying ChenRuya YouKe WangYousheng WangHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Other systems of medicine RZ201-999 |
spellingShingle |
Other systems of medicine RZ201-999 Ying Chen Ruya You Ke Wang Yousheng Wang Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
description |
Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interest in discovering new URAT1 inhibitors and developing technology that can evaluate URAT1 inhibition. This review summarizes the methods for assay of URAT1 inhibition and the progress on the discovery of natural and synthetic URAT1 inhibitors in the past five years. |
format |
article |
author |
Ying Chen Ruya You Ke Wang Yousheng Wang |
author_facet |
Ying Chen Ruya You Ke Wang Yousheng Wang |
author_sort |
Ying Chen |
title |
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
title_short |
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
title_full |
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
title_fullStr |
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
title_full_unstemmed |
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods |
title_sort |
recent updates of natural and synthetic urat1 inhibitors and novel screening methods |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/230e01384c354a898aa66ccf47cbe072 |
work_keys_str_mv |
AT yingchen recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods AT ruyayou recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods AT kewang recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods AT youshengwang recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods |
_version_ |
1718443166456086528 |